Our results show that genetically engineered mice such as IL-10-/- mice, although prone to developing spontaneous colitis, failed to develop sustained chronic colitis with piroxicam promotion for dual-selectin targeted USMI purposes. This evidence concerns the gene IL10 and colitis.